NIH-funded research R21 grant

MAGIC-PHIV: Microbiome, Gut Inflammation, and Metabolic Health in Youth with Perinatally Acquired HIV

Official title: MAGIC-PHIV: Microbiome and Gut Inflammation in Cardiometabolic Health in Youth with Perinatally Acquired HIV

Funded at Lurie Children's Hospital of Chicago · NIH-11400032 · Data updated 2026-11-12

A short, friendly project will study gut health and microbial changes in young people with perinatally acquired HIV to understand links to heart and metabolism as they grow.

More Cardiometabolic Health research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$197,619
NIH project number5R21HD118587-02
Project IDNIH-11400032 on NIH RePORTER

Who could benefit from this research

Could help

YPHIV or adolescents/young adults with perinatally acquired HIV, especially in sub-Saharan Africa and similar settings.

Less likely to help

Individuals without HIV or those outside the study regions may not directly benefit.

What this research studies

This project focuses on adolescents and young adults living with perinatally acquired HIV in sub-Saharan Africa and the United States. It uses a multi-omics approach to examine how gut bacteria, inflammation, and metabolic signals interact, aiming to uncover mechanisms behind cardiometabolic risks. Researchers will compare groups with and without HIV exposure, look at gut barrier integrity, and analyze microbiome function to identify potential inflammatory pathways. The study is designed to generate new insights that could guide future interventions to improve long-term health in YPHIV.

Why it matters

Potential benefit: If successful, the work could inform strategies to reduce inflammation and cardiometabolic risk in youths living with HIV.

How similar studies have gone: Prior research shows links between gut microbiota, inflammation, and metabolic health in HIV, but this project aims to expand and specify these findings in YPHIV.

Where this research is happening

  • Lurie Children's Hospital of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Dirajlal-Fargo, Sahera — Lurie Children's Hospital of Chicago
  • Study coordinator: Dirajlal-Fargo, Sahera

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.